Stanford Medicine study finds inhibiting 15-PGDH enzyme regenerates cartilage in aged mice, offering a non-invasive osteoarthritis treatment that could reduce joint replacements and improve life quali...
Recent advances in mRNA technology for cancer vaccines show promise with improved stability, targeted delivery, and AI-driven antigen design, transforming immunotherapy approaches. Cutting-edge mRNA v...
Recent research shows compounds like P7C3-A20 restore NAD+ levels, reversing Alzheimer’s pathology in mice, with early clinical trials indicating safety and potential efficacy in humans. Breakth...
Advances in mitochondrial uncouplers like BAM15 offer safer options for weight management and anti-aging, supported by 2023 research and ongoing clinical trials targeting metabolic efficiency. Cutting...
In 2025, aging research sees major advancements with senolytics and mitochondrial therapies, backed by clinical trials and shifting medical attitudes towards treating aging as a condition. Recent tria...
Recent phase 2b trials show stem cell-derived patches significantly improve vision in dry AMD patients, with 40% achieving notable gains, marking a leap in regenerative ophthalmology. Breakthrough ste...
Recent research identifies OTULIN as a key regulator of tau in neurons, offering a novel approach for Alzheimer’s disease by modulating production instead of clearance, with potential for person...
Recent animal studies show senolytic vaccines reduce tumor growth by up to 50% when combined with anti-PD-L1, with clinical trials advancing for lung cancer and melanoma. Emerging senolytic vaccines t...
Recent studies reveal UBQLN2’s role in accelerating α-synuclein aggregation through liquid-liquid phase separation, offering new therapeutic targets for Parkinson’s disease and related ne...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
